These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22783102)

  • 1. Hypoglycemic and Hypocholesterolemic Effects of Botryosphaeran from Botryosphaeria rhodina MAMB-05 in Diabetes-Induced and Hyperlipidemia Conditions in Rats.
    Miranda-Nantes CC; Fonseca EA; Zaia CT; Dekker RF; Khaper N; Castro IA; Barbosa AM
    Mycobiology; 2011 Sep; 39(3):187-93. PubMed ID: 22783102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticlastogenic activity exhibited by botryosphaeran, a new exopolysaccharide produced by Botryosphaeria rhodina MAMB-05.
    Miranda CC; Dekker RF; Serpeloni JM; Fonseca EA; Cólus IM; Barbosa AM
    Int J Biol Macromol; 2008 Mar; 42(2):172-7. PubMed ID: 18022685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botryosphaeran, a (1 → 3)(1 → 6)-β-D-glucan, reduces tumor development and cachexia syndrome in obese male rats by increasing insulin sensitivity and FOXO3a activity.
    Geraldelli D; Ribeiro MC; Medeiros TC; Comiran PK; Martins KO; Oliveira MF; Oliveira GA; Dekker RFH; Barbosa-Dekker AM; Alegranci P; Queiroz EAIF
    Int J Biol Macromol; 2020 Dec; 165(Pt A):985-994. PubMed ID: 32991890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor development in rats and cancer cachexia are reduced by treatment with botryosphaeran by increasing apoptosis and improving the metabolic profile.
    Geraldelli D; Ribeiro MC; Medeiros TC; Comiran PK; Martins KO; Oliveira MF; Oliveira GA; Dekker RFH; Barbosa-Dekker AM; Alegranci P; Queiroz EAIF
    Life Sci; 2020 Jul; 252():117608. PubMed ID: 32289434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botryosphaeran reduces obesity, hepatic steatosis, dyslipidaemia, insulin resistance and glucose intolerance in diet-induced obese rats.
    Silva AZ; Costa FPL; Souza IL; Ribeiro MC; Giordani MA; Queiroz DA; Luvizotto RAM; Nascimento AF; Bomfim GF; Sugizaki MM; Dekker RFH; Barbosa-Dekker AM; Queiroz EAIF
    Life Sci; 2018 Oct; 211():147-156. PubMed ID: 30227131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended treatment with (1→3)(1→6)-β-d-glucan (Botryosphaeran) reduces obesity and its comorbidities in high-fat/high-sugar diet-fed rats.
    Ribeiro MC; Silva AZD; Giordani MA; Lira C; Luvizotto RAM; Nascimento AF; Queiroz DA; Dekker RFH; Barbosa-Dekker AM; de Queiroz EAIF
    Cell Biochem Funct; 2022 Oct; 40(7):773-783. PubMed ID: 36111697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo antimutagenic and antiatherogenic effects of the (1 → 3)(1 → 6)-β-d- glucan botryosphaeran.
    Silva-Sena GG; Malini M; Delarmelina JM; Dutra JCV; Gervásio SV; Leal MAS; Costa Pereira TM; Barbosa-Dekker AM; Dekker RFH; de Paula F; Batitucci MDCP
    Mutat Res Genet Toxicol Environ Mutagen; 2018 Feb; 826():6-14. PubMed ID: 29412871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of botryosphaeran [(1 → 3)(1 → 6)-β-d-glucan] reduces inflammation through modulation of leukocytes and has limited effect on inflammatory nociception.
    Silva NA; Pereira BG; Santos JA; Guarnier FA; Barbosa-Dekker AM; Dekker RFH; Kassuya CAL; Bernardes SS
    Cell Biochem Funct; 2022 Aug; 40(6):578-588. PubMed ID: 35788958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant, anti-inflammatory and beneficial metabolic effects of botryosphaeran [(1→3)(1→6)-β-d-glucan] are responsible for its anti-tumour activity in experimental non-obese and obese rats bearing Walker-256 tumours.
    da Silva TP; Geraldelli D; Martins KO; Braga AJL; Rosa AP; Ferneda JMA; Bomfim GF; Barbosa-Dekker AM; Dekker RFH; Dias MC; Paim NP; Sinhorin VDG; de Queiroz EAIF
    Cell Biochem Funct; 2022 Mar; 40(2):213-227. PubMed ID: 35229356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfonation and anticoagulant activity of botryosphaeran from Botryosphaeria rhodina MAMB-05 grown on fructose.
    Mendes SF; dos Santos O; Barbosa AM; Vasconcelos AF; Aranda-Selverio G; Monteiro NK; Dekker RF; Sá Pereira M; Tovar AM; Mourão PA; da Silva Mde L
    Int J Biol Macromol; 2009 Oct; 45(3):305-9. PubMed ID: 19549543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemopreventive effect and lack of genotoxicity and mutagenicity of the exopolysaccharide botryosphaeran on human lymphocytes.
    Malini M; Camargo MS; Hernandes LC; Vargas-Rechia CG; Varanda EA; Barbosa AM; Dekker RFH; Matsumoto ST; Antunes LMG; Cólus IMS
    Toxicol In Vitro; 2016 Oct; 36():18-25. PubMed ID: 27387458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free-radical scavenging properties and antioxidant activities of botryosphaeran and some other β-D-glucans.
    Giese EC; Gascon J; Anzelmo G; Barbosa AM; da Cunha MA; Dekker RF
    Int J Biol Macromol; 2015 Jan; 72():125-30. PubMed ID: 25128096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro protective effects of botryosphaeran, a (1→3;1→6)-β-d-glucan, against mutagens in normal and tumor rodent cells.
    Kerche-Silva LE; Cólus IM; Malini M; Mori MP; Dekker RF; Barbosa-Dekker AM
    Mutat Res Genet Toxicol Environ Mutagen; 2017 Feb; 814():29-36. PubMed ID: 28137365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of gene expression and cell cycle by botryosphaeran, a (1→3)(1→6)-β-d-glucan in human lymphocytes.
    Malini M; Souza MF; Oliveira MT; Antunes LM; Figueiredo SG; Barbosa AM; Dekker RF; Cólus IM
    Int J Biol Macromol; 2015; 77():214-21. PubMed ID: 25795388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical modification of botryosphaeran: structural characterization and anticoagulant activity of a water-soluble sulfonated (1-->3)(1-->6)-β-D-glucan.
    Brandi J; Oliveira ÉC; Monteiro N; Vasconcelos AF; Dekker RF; Barbosa AM; Silveira JL; Mourão PA; Corradi da Silva Mde L
    J Microbiol Biotechnol; 2011 Oct; 21(10):1036-42. PubMed ID: 22031027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botryosphaeran Attenuates Tumor Development and the Cancer Cachexia Syndrome in Walker-256 Tumor-Bearing Obese Rats and Improves the Metabolic and Hematological Profiles of These Rats.
    Comiran PK; Ribeiro MC; Silva JHG; Martins KO; Santos IA; Chiaradia AEF; Silva AZ; Dekker RFH; Barbosa-Dekker AM; Alegranci P; Queiroz EAIF
    Nutr Cancer; 2021; 73(7):1175-1192. PubMed ID: 32643421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicological and immunomodulatory assessments of botryosphaeran (β-glucan) produced by Botryosphaeria rhodina RCYU 30101.
    Weng BB; Lin YC; Hu CW; Kao MY; Wang SH; Lo DY; Lai TY; Kan LS; Chiou RY
    Food Chem Toxicol; 2011 Apr; 49(4):910-6. PubMed ID: 21185904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botryosphaeran and sulfonated derivatives as novel antiviral agents for herpes simplex and dengue fever.
    Sacchelli BAL; Faccin-Galhardi LC; Ito VY; Lopes JL; Dekker RFH; Barbosa-Dekker AM; Orsato A
    Int J Biol Macromol; 2019 Oct; 138():334-339. PubMed ID: 31302130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-(1 → 3)-Glucanolytic yeasts from Brazilian grape microbiota: production and characterization of β-glucanolytic enzymes by Aureobasidium pullulans 1WA1 cultivated on fungal Mycelium.
    Bauermeister A; Amador IR; Pretti CP; Giese EC; Oliveira AL
    J Agric Food Chem; 2015 Jan; 63(1):269-78. PubMed ID: 25559084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Botryosphaeran production by the ascomyceteous fungus Botryosphaeria sp., grown on different carbohydrate carbon sources, and their partial structural features.
    Steluti RM; Giese EC; Piggato MM; Sumiya AF; Covizzi LG; Job AE; Cardoso MS; Corradi da Silva Mde L; Dekker RF; Barbosa AM
    J Basic Microbiol; 2004; 44(6):480-6. PubMed ID: 15558819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.